Clinical Trials

If you would like to explore the possibility of participating in a clinical trial at Guthrie, please call 1-800-836-0388.
Title: A011202: A Randomized Phase III Trial Comparing Axillary Lymph Node Dissection to Axillary Radiation in Breast Cancer Patients (cT1-3 N1) Who Have Positive Sentinel Lymph Node Disease After Neoadjuvant Chemotherapy
Department: Oncology
Diagnosis: Breast
Principal Investigator: Thomas J Gergel, MD
Sponsors: ALLIANCE
Details (Indentifier #): NCT01901094
Title: A011502, A Randomized Phase III Double Blinded Placebo Controlled Trial of Aspirin as Adjuvant Therapy for Node Positive HER2 Negative Breast Cancer: The ABC Trial
Department: Oncology
Diagnosis: Breast
Principal Investigator: Philip A Lowry, MD
Sponsors: ALLIANCE
Details (Indentifier #): NCT02927249
Title: A021502: Randomized Trial of Standard Chemotherapy Alone or Combined with Atezolizumab as Adjuvant Therapy for Patients with Stage III Colon Cancer and Deficient DNA Mismatch Repair
Department: Oncology
Diagnosis: Gastrointestinal - Colon-Rectal
Principal Investigator: Joyson Poulose, MD
Sponsors: ALLIANCE
Details (Indentifier #): NCT02912559
Title: A021703: Randomized Double-Blind Phase III Trial of Vitamin D3 Supplementation in Patients With Previously Untreated Metastatic Colorectal Cancer (SOLARIS)
Department: Oncology
Diagnosis: Gastrointestinal - Colon-Rectal
Principal Investigator: Philip A Lowry, MD
Sponsors: ALLIANCE
Details (Indentifier #): NCT04094688
Title: A031704: PD-Inhibitor (Nivolumab) and Ipilimumab Followed by Nivolumab vs. VEGF TKI Cabozantinib With Nivolumab: A Phase III Trial in Metastatic Untreated Renal Cell Cancer [PDIGREE]
Department: Oncology
Diagnosis: Genito-urinary - Renal
Principal Investigator: Philip A Lowry, MD
Sponsors: ALLIANCE
Details (Indentifier #): NCT03793166
Title: A071801: Phase III Trial of Post-Surgical Single Fraction Stereotactic Radiosurgery (SRS) Compared with Fractionated SRS (FSRS) for Resected Metastatic Brain Disease
Department: Oncology
Diagnosis: Brain
Principal Investigator: Thomas J Gergel, MD
Sub-Investigator(s):
Sponsors: ALLIANCE
Details (Indentifier #): NCT04114981
Title: A081105, Randomized Study of Erlotinib or Observation in Patients with Completely Resected Epidermal Growth Factor Receptor (EGFR) Mutant Non-small Cell Lung Cancer (NSCLC)
Department: Oncology
Diagnosis: Lung- Non-Small Cell
Principal Investigator: Philip A Lowry, MD
Sponsors: ALLIANCE
Details (Indentifier #): NCT02193282
Title: A221505, Hypofractionated Radiation Therapy After Mastectomy in Preventing Recurrence in Patients With Stage IIa-IIIa Breast Cancer
Department: Oncology
Diagnosis: Breast
Principal Investigator: Thomas J Gergel, MD
Sub-Investigator(s):
Sponsors: ALLIANCE
Details (Indentifier #): NCT03414970
Title: A221602: Olanzapine With or Without Fosaprepitant for the Prevention of Chemotherapy Induced Nausea and Vomiting (CINV)in Patients Receiving Highly Emetogenic Chemotherapy (HEC): A Phase III Randomized, Double Blind, Placebo-Controlled Trial
Department: Oncology
Diagnosis: Oncology - General
Principal Investigator: Philip A Lowry, MD
Sponsors: ALLIANCE
Details (Indentifier #): NCT03578081
Title: Adjuvant Lung Cancer Enrichment Marker Identification and Sequencing Trial (ALCHEMIST)
Department: Oncology
Diagnosis: Lung- Miscellaneous
Principal Investigator: Philip A Lowry, MD
Sponsors: ALLIANCE
Details (Indentifier #): NCT02194738
Showing 1-10 of 32 Results